Chemist Receives New, Five-year $651,729 NSF CAREER Award

Tuesday, June 23, 2015 Anne Co’s new, five-year $651,729 NSF CAREER Award for “Control of surface reactivity for catalyzing hydrocarbon formation from CO₂,” will allow her to expand her research on advanced  electrocatalytic materials for chemical conversion and energy storage. Co, assistant professor, chemistry and biochemistry; and her students, focus on fundamental studies of electrochemical Read the full article…

Symposium on Drug Discovery and Development

Sponsored by The Ohio State University Drug Development Institute and Charles River Laboratories Tuesday, April 28th 10:00am – 2:00pm Biomedical Research Tower, Room 115 460 West 12th Avenue Columbus, Ohio 43210 Ohio State’s Drug Development Institute and Charles River Laboratories are happy to announce a symposium detailing the drug discovery and development process as it Read the full article…

Columbus Research Breakthroughs

Credit to Columbus Business First,  Paula Christian: published January 30, 2015   With so much health care research taking place here, Columbus Business First took a look at five innovations that, while in infancy now, could change patient care someday. Plenty of ideas germinated locally already have made it to market. Take the EpiGlare patented Read the full article…

Commercialization Workshop Series Launches January 2015

The Commercialization Workshop Series walks participants through the commercialization process in eight workshops spanning January through August. Each interactive workshop will have subject matter experts discussing the topics while referencing a technology from Ohio State that has been commercialized. Come learn about commercialization and what resources are available to aid faculty and staff in that Read the full article…

The Ohio State University and University of Michigan Partner with Industry to Bring Oral Cancer-Fighting Patch to Patients

Ohio-based Venture Therapeutics Named Industry Partner COLUMBUS, Ohio – The Ohio State University and the University of Michigan have signed an exclusive worldwide agreement with Ohio-based Venture Therapeutics, Inc., to form a new company to develop and commercialize a pharmaceutical technology targeted for the treatment of precancerous oral lesions. These lesions are currently managed by Read the full article…

Ohio State Partners with MedVax Technologies, Inc. to Bring a Cancer Peptide Vaccine to Patients

COLUMBUS, Ohio, and MIAMI, Florida–The Ohio State University, through the Ohio State Innovation Foundation, has signed an exclusive world-wide licensing agreement with MedVax Technologies, Inc., for the licensing of groundbreaking cancer peptide vaccine technologies. The anticancer vaccine technologies are designed for the treatment and prevention of cancers associated with the HER2 protein. These include breast, ovarian, Read the full article…

Ohio State Partners with Signet Accel LLC

Ohio State Partners with Signet Accel LLC to Accelerate Health Care Data Sharing Worldwide Agreement includes largest up-front licensing fee  COLUMBUS, Ohio – The Ohio State University today announced the signing of an exclusive worldwide agreement with a new company formed by Signet Enterprises: Signet Accel LLC. The new company will license a portfolio of Read the full article…